Effectiveness and safety analysis of Danggui Shaoyao Powder for the treatment of non-alcoholic fatty liver disease: study protocol for a randomized, double-blind, placebo-controlled clinical trial

Effectiveness and safety analysis of Danggui Shaoyao Powder for the treatment of non-alcoholic fatty liver disease: study protocol for a randomized, double-blind, placebo-controlled clinical trial

Abstract Background The incidence of non-alcoholic fatty liver disease (NAFLD) has been on the rise in recent years, and there are no effective drugs to treat NAFLD; therefore, effective prevention and treatment of NAFLD have become a new challenge. Danggui Shaoyao Powder (DGSY) is a classic prescri...

Full description

Bibliographic Details
Main Authors: Qian Huang, Ziming An, Xin Xin, Qinmei Sun, Siting Gao, Sheng Lv, Xiao Xu, Shuohui Yang, Fang Lu, Jie Yuan, Yu Zhao, Yiyang Hu, Ping Liu, Qin Feng
Format: Article
Language:English
Published: BMC 2023-04-01
Series:BMC Complementary Medicine and Therapies
Subjects:
Danggui Shaoyao Powder
Non-alcoholic fatty liver disease
Randomized controlled trial
Traditional Chinese medicine
Online Access:https://doi.org/10.1186/s12906-023-03948-3

Internet

https://doi.org/10.1186/s12906-023-03948-3

Similar Items